Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
07/2003
07/03/2003CA2470808A1 Piperazine derivative
07/03/2003CA2469278A1 Isochroman compounds for treatment of cns disorders
07/02/2003EP1323830A2 Process for the preparation of heterocyclic (R)- and (S)-cyanohydrines
07/02/2003EP1323724A2 Novel ruthenium complexes and process for preparing alcoholic compounds using these
07/02/2003EP1323716A1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells
07/02/2003EP1323715A1 Inhibitors of cholesterol esterase
07/02/2003EP1323700A1 process for producing hydrogenated aromatic polycarboxylic acid and process for producing hydrogenated aromatic polycarboxylic anhydride
07/02/2003EP1322630A2 Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia
07/02/2003EP1322629A1 Tetrahydrofuran derivatives and their use as nk-1 antagonists
07/02/2003EP1322599A2 Hiv integrase inhibitors
07/02/2003EP1322598A1 Nitroso diphenylamine derivatives
07/02/2003EP1322590A1 5-amino-1-pentene-3-ol substituted derivatives
07/02/2003EP1165580B1 Catalytic method for modifying carbohydrates, alcohols, aldehydes or polyhydroxy compounds
07/02/2003EP0970067B1 (methylsulfonyl)phenyl-2-(5h)-furanones with oxygen link as cox-2 inhibitors
07/02/2003EP0848700B1 Acylaminosalicylic acid amides and their uses as pesticides
07/02/2003CN1427835A Stepwise Alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
07/02/2003CN1427834A Process for preparation of citalopram
07/02/2003CN1427833A Method for production of L-ascorbic acid by lactonisation of 2-keto-L-gulonic acid or 2-keto-L-gulonate esters
07/02/2003CN1427832A Method for distillative separation of mixtures containing tetrahydrofuran, gamma-butyrolactone and/or 1,4-butanediol
07/02/2003CN1113062C Dihydrofuran carboxamides, its preparing process and use
07/01/2003US6586627 N-protected/N-substituted-beta-amino hydroxy sulfonates
07/01/2003US6586620 Process for the preparation of alkyl 3-oxo-2-pentyl-1-cyclopenteneacetates
07/01/2003US6586606 Process for the preparation of 3-aryl-benzofuran-2-ones
07/01/2003US6586554 Polyarylene and method for production thereof
07/01/2003US6586467 Tyrosine phosphatase inhibitors useful in the treatment or prevention of Type II Diabetes Mellitus
07/01/2003US6586466 Carbohydrazide-protease inhibitors
07/01/2003US6586461 Geranylgeranyl transferase inhibitors comprising farnesol and geranylgeraniol analogs, used as anticarcinogenic agents and for prevention of restenosis
07/01/2003US6586442 Benzofurane derivatives, their preparation process, their use as medicaments and the pharmaceutical compositions containing them
07/01/2003US6586433 Anticholesterol agents; antilipemic agents; cardiovascular disorders
07/01/2003US6586361 Comprising vanadium oxide, titanium dioxide, cesium compound, phosphorous compound, and antimony oxide; carboxylation, anhydriding
06/2003
06/28/2003CA2414265A1 Novel ruthenium complexes and process for preparing alcoholic compounds using these
06/27/2003CA2415185A1 Process for preparing heterocyclic (r)- and (s)-cyanohydrins
06/26/2003WO2003051861A1 Method for the preparation of escitalopram
06/26/2003WO2003051860A2 Substituted 2-phenyl benzofurans as estrogenic agents
06/26/2003WO2003051859A1 Compounds for imaging alzheimer's disease
06/26/2003WO2003051858A1 Method of obtaining 2-(2-nitrovinyl)-furan and the use thereof as a coccidiostatic
06/26/2003WO2003051857A2 Furanone synthesis
06/26/2003WO2003051856A1 Process for producing 5-alkyl-ϝ-butyrolactone
06/26/2003WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051824A1 α-CYANOACRYLATES
06/26/2003WO2003051823A1 Beta-amino-alpha-cyanoacrylates and their use as herbicides
06/26/2003WO2003051352A1 Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
06/26/2003WO2003002491A3 ENANTIOSELECTIVE TRANSFORMATION OF α, β-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS
06/26/2003US20030120111 Catalysts and processes for the conversion of succinates to citraconates or itaconates
06/26/2003US20030120110 Contacting molar excess of aqueous solution of formaldehyde, gaseous formaldehyde or trioxane in solvent with succinic anhydride or lower alkyl succinate in vapor phase with porous metal oxide catalyst at elevated temperature and pressure
06/26/2003US20030120091 Method for producing optically active lactone compounds by using salen cobalt complexes having a cis-beta structure
06/26/2003US20030120089 Anhydride stabilization
06/26/2003US20030120080 Such as (2S)-2-((4S)-4-(2,2-difluorovinyl)-2-oxopyrrolidinyl) butanamide; antiepileptic agents; anticonvulsants
06/26/2003US20030120073 Such as d-4-hydroxyphenylglycine methyl ester for treatment of autoimmune diseases, glucose intolerance, diabetes, obesity, cancer, and psoriasis; drug screening
06/26/2003US20030119914 Bis(thio-hydrazide amide) compounds; anticancer agents
06/26/2003US20030119907 Accelerating uncoupled respiration and proton leak of the inner membrane of mitochondria which are induced by uncoupling proteins usingcoupled isomerized highly unsaturated fatty acids
06/26/2003US20030119902 Novel aminobenzoephenones
06/26/2003US20030119899 Making 3-amido-5-oxy-furan-2-one derivatives by aziding a butenlactone, converting to an amino or an iminophosphorane and coupling with an acid; caspase inhibitors
06/26/2003US20030119876 Compounds for the treatment of protozoal diseases
06/26/2003US20030119833 Treating cardiovascular diseases
06/26/2003US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases
06/26/2003US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors
06/26/2003US20030119753 Novel ascorbic acid compounds, methods of synthesis and application use thereof
06/26/2003US20030119721 Electrophilic ketones for the treatment of herpesvirus infections
06/26/2003CA2470352A1 Substituted 2-phenyl benzofurans as estrogenic agents
06/26/2003CA2470225A1 Method for the preparation of escitalopram
06/26/2003CA2470156A1 .beta.-amino-.alpha.-cyanoacrylates and their use as herbicides
06/26/2003CA2469716A1 .alpha.-cyanoacrylates
06/26/2003CA2469663A1 Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003CA2466010A1 Method of obtaining 2-(2-nitrovinyl)-furan and the use thereof as a coccidiostatic
06/25/2003EP1321464A1 Process for the preparation of 5-cyanophthalide and intermediates useful therein
06/25/2003EP1320528A2 Substituted phthalides as anti-convulsive drugs
06/25/2003EP1320523A2 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/25/2003EP1320520A1 Sulfonylguanidine
06/25/2003EP1320363A1 Lactone integrin antagonists
06/25/2003EP1025086B1 Benzamidine derivatives as factor xa inhibitors
06/25/2003EP0808172B1 Combination of angiotensin converting enzyme inhibitor and aldosterone antagonist for the treatment of ventricular hypertrophy
06/25/2003CN1426391A Polyamine analogues as cytotoxic agents
06/25/2003CN1425660A Di (trialkylbenzotri acid anhydride) devivative for optic communication
06/25/2003CN1425659A Process for preparing danshen salviandic acid
06/25/2003CN1425658A Synthetic method for (S)-3-hydroxy-gamma-butyrolactone
06/25/2003CN1112356C Nitromethylthiobenzene derivative as inhibitors of aldose reductase
06/25/2003CN1112343C Skin lightening compositions
06/24/2003US6584266 Dicyanomethylenedihydrofuran compounds and polymer pendant groups having electron withdrawing groups and bivalent cyclic bridges
06/24/2003US6583319 Cyclic compounds having a cycloalkylene chain
06/24/2003US6583299 α-amino-β-sulfonyl hydroxamic acid compounds
06/24/2003US6583286 Method for hydrogenating unsaturated heterocyclic compounds
06/24/2003US6583282 Formation of a urea by reacting an aromatic carbamate with a aromatic amine
06/24/2003US6583183 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
06/24/2003US6583177 Leukotriene B4 antagonist compounds and method for treatment
06/24/2003US6583175 Used as insect growth regulatory for pest management in agricultural fields no or less environmental impact
06/24/2003US6583165 Anticarcinogenic, -inflammatory and -proliferative agents; viricides; bactericides; vascular restenosis, autoimmune diseases; psoriasis; anticolesterol and -lipemic agents
06/24/2003US6582688 Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado, composition based on said compounds, and therapeutic, cosmetical or food use of said compounds
06/24/2003CA2126337C 2-amino-1,3-propanediol compound and immunosuppressant
06/19/2003WO2003050165A1 Methods for the preparation of poly(etherimides)s
06/19/2003WO2003050154A2 Catalytic carbonylation of three and four membered heterocycles
06/19/2003WO2003050103A1 Preparation of substituted phthalic anhydrides and substituted phthalimides
06/19/2003WO2003050102A1 Novel compounds for the treatment of cardiac arrhythmia, synthesis, and methods of use
06/19/2003WO2003050101A1 Deuterated substituted dihydrofuranones and medicaments containing these compounds
06/19/2003WO2003050062A2 PRODUCTION OF CHIRALLY PURE α-AMINO ACIDS ADN N-SULFONYL α-AMINO ACIDS
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003WO2003049698A2 Substituted hydrazones as inhibitors of cyclooxygenase-2
06/19/2003US20030114693 Method of preparing optically pure (R) - or (S) - tetrahydrofuranyl ketone
1 ... 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 ... 472